Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 830 · SAFE Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

21 U.S.C. § 811 Authority and criteria for classification of substances

+82 −0Shown
More for 21 U.S.C. § 811
Read § 811Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 201 of the Controlled Substances Act (21 U.S.C. 811) is amended by adding at the end the following new subsection:(k) Removal from schedule I of fentanyl-Related substances.— (1) Determination resulting in removal.— If the Secretary determines, taking into consideration factors as set forth in paragraph (3), that a fentanyl-related substance has a potential for abuse that is less than the …

§ 811(j)–(k)

Start of § 811 to (j)(2)(A) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(j)(2)(B)(B) (B)
the date on which the Attorney General receives notification from the Secretary of Health and Human Services that the Secretary has approved an application under section 505(c), 512, or 571 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355(c), 360b, 360ccc] or section 262(a) of title 42, or indexed a drug under section 572 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360ccc–1], with respect to the drug described in paragraph (1).the date on which the Attorney General receives notification from the Secretary of Health and Human Services that the Secretary has approved an application under section 505(c), 512, or 571 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355(c), 360b, 360ccc] or section 262(a) of title 42, or indexed a drug under section 572 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360ccc–1], with respect to the drug described in paragraph (1).
(j)(3)(3) (3)
A rule issued by the Attorney General under paragraph (1) shall become immediately effective as an interim final rule without requiring the Attorney General to demonstrate good cause therefor. The interim final rule shall give interested persons the opportunity to comment and to request a hearing. After the conclusion of such proceedings, the Attorney General shall issue a final rule in accordance with the scheduling criteria of subsections (b), (c), and (d) of this section and section 812(b) of this title.A rule issued by the Attorney General under paragraph (1) shall become immediately effective as an interim final rule without requiring the Attorney General to demonstrate good cause therefor. The interim final rule shall give interested persons the opportunity to comment and to request a hearing. After the conclusion of such proceedings, the Attorney General shall issue a final rule in accordance with the scheduling criteria of subsections (b), (c), and (d) of this section and section 812(b) of this title.
(k)(k) [inserted: Removal from schedule I of fentanyl-Related substances.—]
(k)(1)(1) [inserted: Determination resulting in removal.—]
[inserted: If the Secretary determines, taking into consideration factors as set forth in paragraph (3), that a fentanyl-related substance has a potential for abuse that is less than the drugs or other substances in schedule V—]
(k)(1)(A)(A) [inserted: ]
[inserted: the Secretary shall submit to the Attorney General a scientific and medical evaluation of that fentanyl-related substance supporting that determination;]
(k)(1)(B)(B) [inserted: ]
[inserted: the Secretary shall submit any such evaluation and determination in writing and include the bases therefor;]
(k)(1)(C)(C) [inserted: ]
[inserted: the scientific and medical determination of the Secretary contained in such evaluation shall be binding on the Attorney General; and]
(k)(1)(D)(D) [inserted: ]
[inserted: not later than 90 days after receiving such evaluation and determination, the Attorney General shall issue an order removing such fentanyl-related substance from the schedules under section 202.]
(k)(2)(2) [inserted: Determination resulting in rescheduling.—]
[inserted: If the Secretary determines, taking into consideration factors as set forth in paragraph (3), that a fentanyl-related substance has a potential for abuse that is less than the drugs or other substances in schedules I and II—]
(k)(2)(A)(A) [inserted: ]
[inserted: the Secretary shall submit to the Attorney General a scientific and medical evaluation of that fentanyl-related substance supporting that determination;]
(k)(2)(B)(B) [inserted: ]
[inserted: the Secretary shall submit any such evaluation and determination in writing and include the bases therefor;]
(k)(2)(C)(C) [inserted: ]
[inserted: the scientific and medical determination of the Secretary contained in such evaluation shall be binding on the Attorney General; and]
(k)(2)(D)(D) [inserted: ]
[inserted: not later than 90 days after receiving such evaluation, the Attorney General shall issue an order removing such fentanyl-related substance from schedule I and controlling such substance under schedule III.]
(k)(3)(3) [inserted: Evaluation factors.—]
(k)(3)(A)(A) [inserted: In general.—]
[inserted: In making a determination under paragraph (1) or (2), the Secretary—]
(k)(3)(A)(i)(i) [inserted: ]
[inserted: shall consider—]
(k)(3)(A)(i)(I)(I) [inserted: ]
[inserted: the factor listed in paragraph (2) of subsection (c);]
(k)(3)(A)(i)(II)(II) [inserted: ]
[inserted: the factors listed in paragraphs (1), (3), and (6) of such subsection to the extent evidence exists with respect to such factors; and]
(k)(3)(A)(i)(III)(III) [inserted: ]
[inserted: any information submitted to the Secretary by the Attorney General for purposes of such determination; and]
(k)(3)(A)(ii)(ii) [inserted: ]
[inserted: may consider the factors listed in paragraphs (4), (5), and (7) of subsection (c) if the Secretary finds that evidence exists with respect to such factors.]
(k)(3)(B)(B) [inserted: Consideration of scientific evidence of pharmacological effect.—]
(k)(3)(B)(i)(i) [inserted: In general.—]
[inserted: For the purposes of subparagraph (A)(i)(I), consideration by the Secretary of the results of an assessment consisting of the studies described in clause (ii) shall suffice to constitute consideration of the factor listed in paragraph (2) of subsection (c) if—]
(k)(3)(B)(i)(I)(I) [inserted: ]
[inserted: each such study is performed according to scientific methods and protocols commonly accepted in the scientific community; and]
(k)(3)(B)(i)(II)(II) [inserted: ]
[inserted: the Secretary determines that such assessment is adequate for such purposes.]
(k)(3)(B)(ii)(ii) [inserted: Described studies.—]
[inserted: The studies described in this clause are any of the following:]
(k)(3)(B)(ii)(I)(I) [inserted: ]
[inserted: A receptor binding study that can demonstrate whether the substance has affinity for the human mu opioid receptor.]
(k)(3)(B)(ii)(II)(II) [inserted: ]
[inserted: An in vitro functional assay that can demonstrate whether the substance has agonist activity at the human mu opioid receptor.]
(k)(3)(B)(ii)(III)(III) [inserted: ]
[inserted: One or more in vivo animal behavioral studies that can demonstrate whether the substance has abuse-related drug effects consistent with mu opioid agonist activity, such as demonstrating similarity to the effects of morphine.]
(k)(4)(4) [inserted: Advance notice regarding evaluation and conclusion.—]
[inserted: The Secretary shall give the Attorney General at least 30 days notice before sending the Attorney General an evaluation and determination under paragraph (1) or (2) with respect to a fentanyl-related substance.]
(k)(5)(5) [inserted: Exception for treaty obligations.—]
[inserted: If a fentanyl-related substance is a substance that the United States is obligated to control under international treaties, conventions, or protocols in effect on the date of enactment of the Save Americans from the Fentanyl Emergency Act, this subsection shall not require the Attorney General—]
(k)(5)(A)(A) [inserted: ]
[inserted: to remove such substance from control; or]
(k)(5)(B)(B) [inserted: ]
[inserted: to place such substance in a schedule less restrictive than that which the Attorney General determines is necessary to carry out such obligations.]
(k)(6)(6) [inserted: Identification of fentanyl-related substances.—]
[inserted: If the Attorney General or any official of the Department of Justice determines that a substance is a fentanyl-related substance, the Attorney General shall—]
(k)(6)(A)(A) [inserted: ]
[inserted: within 30 days of such determination, notify the Secretary; and]
(k)(6)(B)(B) [inserted: ]
[inserted: include in such notification the identity of the substance, its structure, and the basis for the determination.]
(k)(7)(7) [inserted: Petitions for removing a fentanyl-related substance.—]
(k)(7)(A)(A) [inserted: In general.—]
[inserted: If a person petitions the Attorney General to remove a fentanyl-related substance from schedule I(e) or to reschedule such a substance to another schedule, the Attorney General shall consider such a petition in accordance with the procedures and standards set forth in—]
(k)(7)(A)(i)(i) [inserted: ]
[inserted: subsections (a) and (b) of this section; and]
(k)(7)(A)(ii)(ii) [inserted: ]
[inserted: section 1308.43 of title 21, Code of Federal Regulations (or any successor regulations).]
(k)(7)(B)(B) [inserted: Attorney General to inform Secretary.—]
[inserted: Within 30 days of receiving such a petition, the Attorney General shall forward a copy of the petition to the Secretary.]
(k)(7)(C)(C) [inserted: Determination procedure not precluded by filing of petition.—]
[inserted: The filing of a petition under this paragraph shall not preclude the Secretary from making a determination and sending an evaluation under paragraph (1) or (2).]
(k)(8)(8) [inserted: Rule of construction.—]
[inserted: Nothing in this subsection shall be construed to preclude the Attorney General from transferring a substance listed in schedule I to another schedule, or removing such substance entirely from the schedules, pursuant to other provisions of this section and section 202.]
(k)(9)(9) [inserted: Subsequent controlling of removed substance.—]
[inserted: A substance removed from schedule I pursuant to this subsection may, at any time, be controlled pursuant to the other provisions of this section and section 202 without regard to the removal pursuant to this subsection.]
(k)(10)(10) [inserted: Evaluations or studies.—]
[inserted: The Secretary may enter into contracts or other agreements to conduct or support evaluations or studies of fentanyl-related substances.]
(k)(11)(11) [inserted: Definition.—]
[inserted: In this subsection, the term “fentanyl-related substance” means a fentanyl-related substance as defined in schedule I(e) of section 202(c).]

21 U.S.C. § 822 Persons required to register

+56 −04 of 5 shown
More for 21 U.S.C. § 822
Read § 822Only this section
5 changes the bill asks for here, 4 carried out
  1. Carried out:

    Subsection (c) of section 302 of the Controlled Substances Act (21 U.S.C. 822) is amended by adding at the end the following:(4) An agent or employee of a research institution that is conducting research with a controlled substance if— (A) such agent or employee is acting within the scope of his or her professional practice; (B) another agent or employee of such institution is registered to conduct …

    The section already has a provision under this letter or number, so it would have two.

  2. Not carried out:

    by striking (f) The and inserting (f)(1) The; and

    “(f) The” isn't in § 822(f) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“(f) The” not found in /us/usc/t21/s822/f
  3. Carried out:

    by adding at the end the following:(2) (A) A new inspection by the Attorney General of a registered location is not required if a person is registered under this title to conduct research with a controlled substance and applies for a registration, or for a modification of a registration, to conduct research with …

    The section already has a provision under this letter or number, so it would have two.

  4. Carried out:

    Section 302 of the Controlled Substances Act (21 U.S.C. 822) is amended by adding at the end the following:(h) Continuation of research on substances newly added to schedule I.— If a person is conducting research on a substance at the time the substance is added to schedule I, and such person is already registered under this title to conduct research with a controlled substance in …

    The section already has a provision under this letter or number, so it would have two.

  5. Carried out:

    Section 302 of the Controlled Substances Act (21 U.S.C. 822), as amended by subsection (e), is further amended by adding at the end the following:(i) Treatment of certain manufacturing activities as coincident to research.— (1) In general.— Except as specified in paragraph (3), a person who is registered to perform research on a controlled substance may perform manufacturing activities with small quantities of that …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

§ 822(c)–(e)

Start of § 822 to (c)(4)(C)(ii) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(c)(4)(C)(iii)(iii) (iii)
affirms that any act taken by that agent or employee involving a controlled substance shall be attributable to the registered researcher, as if the researcher had directly committed the act, for purposes of any proceeding under section 824(a) of this title to suspend or revoke the registration of the registered researcher; andaffirms that any act taken by that agent or employee involving a controlled substance shall be attributable to the registered researcher, as if the researcher had directly committed the act, for purposes of any proceeding under section 824(a) of this title to suspend or revoke the registration of the registered researcher; and
(c)(4)(D)(D) (D)
the Attorney General does not, within 30 days of receiving the information, authorization, and affirmation described in subparagraph (C), refuse, for a reason listed in section 824(a) of this title, to allow the agent or employee to possess the substance without a separate registration.the Attorney General does not, within 30 days of receiving the information, authorization, and affirmation described in subparagraph (C), refuse, for a reason listed in section 824(a) of this title, to allow the agent or employee to possess the substance without a separate registration.
(c)(4)(4) [inserted: ]
[inserted: An agent or employee of a research institution that is conducting research with a controlled substance if—]
(c)(4)(A)(A) [inserted: ]
[inserted: such agent or employee is acting within the scope of his or her professional practice;]
(c)(4)(B)(B) [inserted: ]
[inserted: another agent or employee of such institution is registered to conduct research with a controlled substance in the same schedule;]
(c)(4)(C)(C) [inserted: ]
[inserted: the researcher who is so registered—]
(c)(4)(C)(i)(i) [inserted: ]
[inserted: informs the Attorney General of the name, position title, and employing institution of the agent or employee who is not separately registered;]
(c)(4)(C)(ii)(ii) [inserted: ]
[inserted: authorizes such agent or employee to perform research under the registered researcher’s registration; and]
(c)(4)(C)(iii)(iii) [inserted: ]
[inserted: affirms that all acts taken by such agent or employee involving controlled substances shall be attributable to the registered researcher, as if the researcher had directly committed such acts, for purposes of any proceeding under section 304(a) to suspend or revoke the registration of the registered researcher; and]
(c)(4)(D)(D) [inserted: ]
[inserted: the Attorney General does not, within 30 days of receiving the information, authorization, and affirmation described in subparagraph (C), refuse, for a reason listed in section 304(a), to allow such agent or employee to possess such substance without a separate registration.]
(d)(d) Waiver(d) Waiver
The Attorney General may, by regulation, waive the requirement for registration of certain manufacturers, distributors, or dispensers if he finds it consistent with the public health and safety.The Attorney General may, by regulation, waive the requirement for registration of certain manufacturers, distributors, or dispensers if he finds it consistent with the public health and safety.
(e)(e) Separate registration(e) Separate registration

§ 822(f)–(g)

(e)(1)–(f)(2) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(f)(2)(A)(A) (A)
If a person is registered to conduct research with a controlled substance and applies for a registration, or for a modification of a registration, to conduct research with a second controlled substance that is in the same schedule as the first controlled substance, or is in a schedule with a higher numerical designation than the schedule of the first controlled substance, a new inspection by the Attorney General of the registered location is not required.If a person is registered to conduct research with a controlled substance and applies for a registration, or for a modification of a registration, to conduct research with a second controlled substance that is in the same schedule as the first controlled substance, or is in a schedule with a higher numerical designation than the schedule of the first controlled substance, a new inspection by the Attorney General of the registered location is not required.
(f)(2)(B)(B) (B)
Nothing in subparagraph (A) shall prohibit the Attorney General from conducting an inspection that the Attorney General determines necessary to ensure that a registrant maintains effective controls against diversion.Nothing in subparagraph (A) shall prohibit the Attorney General from conducting an inspection that the Attorney General determines necessary to ensure that a registrant maintains effective controls against diversion.
(f)(2)(2) [inserted: ]
(f)(2)(A)(A) [inserted: ]
[inserted: A new inspection by the Attorney General of a registered location is not required if a person is registered under this title to conduct research with a controlled substance and applies for a registration, or for a modification of a registration, to conduct research with a second controlled substance that is—]
(f)(2)(A)(i)(i) [inserted: ]
[inserted: in the same schedule as the first controlled substance; or]
(f)(2)(A)(ii)(ii) [inserted: ]
[inserted: is in a schedule with a higher numerical designation than the schedule of the first controlled substance.]
(f)(2)(B)(B) [inserted: ]
[inserted: Nothing in this paragraph shall prohibit the Attorney General from conducting any inspection if the Attorney General deems it necessary to ensure that the registrant maintains effective controls against diversion.]
(g)(g) Delivery of controlled substances by ultimate users for disposal(g) Delivery of controlled substances by ultimate users for disposal
(g)(1)(1) (1)
An ultimate user who has lawfully obtained a controlled substance in accordance with this subchapter may, without being registered, deliver the controlled substance to another person for the purpose of disposal of the controlled substance if—An ultimate user who has lawfully obtained a controlled substance in accordance with this subchapter may, without being registered, deliver the controlled substance to another person for the purpose of disposal of the controlled substance if—

§ 822(i)–(i)

(g)(1)(A)–(i)(2)(A) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(i)(2)(B)(B) (B)
dosage form development studies performed for the purpose of requesting an investigational new drug exemption under section 355(i) of this title.dosage form development studies performed for the purpose of requesting an investigational new drug exemption under section 355(i) of this title.
(i)(3)(3) Exception regarding marihuana(3) Exception regarding marihuana
The authority under paragraph (1) to manufacture substances does not include the authority to grow marihuana.The authority under paragraph (1) to manufacture substances does not include the authority to grow marihuana.
(h)(h) [inserted: Continuation of research on substances newly added to schedule I.—]
[inserted: If a person is conducting research on a substance at the time the substance is added to schedule I, and such person is already registered under this title to conduct research with a controlled substance in schedule I, then—]
(h)(1)(1) [inserted: ]
[inserted: the person shall, within 90 days of the scheduling in schedule I, submit a completed application for registration under this title or modification of an existing registration under this title, to conduct research on such substance, in accordance with regulations issued by the Attorney General;]
(h)(2)(2) [inserted: ]
[inserted: the person may, notwithstanding subsections (a) and (b), continue to conduct the research on such substance until—]
(h)(2)(A)(A) [inserted: ]
[inserted: the person withdraws such application; or]
(h)(2)(B)(B) [inserted: ]
[inserted: the Attorney General serves on the person an order to show cause proposing the denial of the application pursuant to section 304(c);]
(h)(3)(3) [inserted: ]
[inserted: if the Attorney General serves such an order to show cause and the person requests a hearing, such hearing shall be held on an expedited basis and not later than 45 days after the request is made, except that the hearing may be held at a later time if so requested by the person; and]
(h)(4)(4) [inserted: ]
[inserted: if the person sends a copy of the application required by paragraph (1) to a manufacturer or distributor of such substance, receipt of such copy by such manufacturer or distributor shall constitute sufficient evidence that the person is authorized to receive such substance.]
(i)(i) [inserted: Treatment of certain manufacturing activities as coincident to research.—]
(i)(1)(1) [inserted: In general.—]
[inserted: Except as specified in paragraph (3), a person who is registered to perform research on a controlled substance may perform manufacturing activities with small quantities of that substance, including activities listed in paragraph (2), without being required to obtain a manufacturing registration, if such activities are performed for the purpose of the research and if the activities and the quantities of the substance involved in those activities are stated in—]
(i)(1)(A)(A) [inserted: ]
[inserted: a notification submitted to the Attorney General under section 303(m);]
(i)(1)(B)(B) [inserted: ]
[inserted: a protocol filed with an application for registration approval under section 303(f); or]
(i)(1)(C)(C) [inserted: ]
[inserted: a notification to the Attorney General that includes the registrant’s name and an attestation that the research to be conducted with the small quantities of manufactured substance is consistent with the scope of the research that is the basis for the registration.]
(i)(2)(2) [inserted: Activities included.—]
[inserted: Activities permitted under paragraph (1) include—]
(i)(2)(A)(A) [inserted: ]
[inserted: processing the substance to create extracts, tinctures, oils, solutions, derivatives, or other forms of the substance consistent with the information provided as part of a notification submitted to the Attorney General under section 303(m) or a research protocol filed with the application for registration approval; and]
(i)(2)(B)(B) [inserted: ]
[inserted: dosage form development studies performed for the purpose of satisfying regulatory requirements of the Food and Drug Administration for submitting an investigational new drug application.]
(i)(3)(3) [inserted: Exception regarding marihuana.—]
[inserted: The authority under paragraph (1) to manufacture substances does not include authority to grow marihuana.]

21 U.S.C. § 823 Registration requirements

+54 −0Shown
More for 21 U.S.C. § 823
Read § 823Only this section
2 changes the bill asks for here, 2 carried out
  1. Carried out:

    Section 303 of the Controlled Substances Act (21 U.S.C. 823) is amended by adding at the end the following new subsection:(m) Special provisions for those conducting certain research with schedule I controlled substances.— (1) In general.— Notwithstanding subsection (f), a practitioner may conduct research that is described in paragraph (2) and that is with one or more controlled substances in …

    The section already has a provision under this letter or number, so it would have two.

  2. Carried out:

    Section 303 of such Act (21 U.S.C. 823), as amended by subsection (a), is further amended by adding at the end the following:(n) Transparency regarding special procedures.— (1) In general.— If the Attorney General determines, with respect to a controlled substance, that an application by a practitioner to conduct research with such substance should be considered under a process, or subject to …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

§ 823(o)–(n)

Start of § 823 to (o)(1)(B) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(o)(1)(C)(C) (C)
how the process and criteria described in subparagraph (B) differ from the process and criteria applicable to applications to conduct research with other controlled substances in the same schedule.how the process and criteria described in subparagraph (B) differ from the process and criteria applicable to applications to conduct research with other controlled substances in the same schedule.
(o)(2)(2) Timing of posting(2) Timing of posting
The Attorney General shall make information described in paragraph (1) public upon making a determination described in that paragraph, regardless of whether a practitioner has submitted such an application at that time.The Attorney General shall make information described in paragraph (1) public upon making a determination described in that paragraph, regardless of whether a practitioner has submitted such an application at that time.
(m)(m) [inserted: Special provisions for those conducting certain research with schedule I controlled substances.—]
(m)(1)(1) [inserted: In general.—]
[inserted: Notwithstanding subsection (f), a practitioner may conduct research that is described in paragraph (2) and that is with one or more controlled substances in schedule I if one of the following conditions is satisfied:]
(m)(1)(A)(A) [inserted: Researcher with a current schedule I or II research registration.—]
[inserted: If the practitioner is registered to conduct research with a controlled substance in schedule I or II, the practitioner may conduct research under this paragraph 30 days after the practitioner has sent a notice to the Attorney General containing the following information, with respect to each substance with which the research will be conducted:]
(m)(1)(A)(i)(i) [inserted: ]
[inserted: The chemical name of the substance.]
(m)(1)(A)(ii)(ii) [inserted: ]
[inserted: The quantity of the substance to be used in such research.]
(m)(1)(A)(iii)(iii) [inserted: ]
[inserted: Demonstration that the research is described in paragraph (2), which demonstration can be satisfied—]
(m)(1)(A)(iii)(I)(I) [inserted: ]
[inserted: in the case of research described in paragraph (2)(A), by supplying the number of the application submitted under section 505(i) of the Federal Food, Drug, and Cosmetic Act or section 351(a)(3) of the Public Health Service Act and the sponsor of record on such application; or]
(m)(1)(A)(iii)(II)(II) [inserted: ]
[inserted: in the case of research described in paragraph (2)(B), by identifying the sponsoring agency and supplying the number of the grant, contract, cooperative agreement, other transaction, or project.]
(m)(1)(A)(iv)(iv) [inserted: ]
[inserted: Demonstration that the researcher is authorized to conduct research with respect to the substance under the laws of the State in which the research will take place.]
(m)(1)(B)(B) [inserted: Researcher without a current schedule I or II research registration.—]
[inserted: If the practitioner is not currently registered to conduct research with a controlled substance in schedule I or II—]
(m)(1)(B)(i)(i) [inserted: ]
[inserted: the practitioner may send a notice to the Attorney General containing the information listed in subparagraph (A), with respect to each substance with which the research will be conducted;]
(m)(1)(B)(ii)(ii) [inserted: ]
[inserted: the Attorney General shall treat such notice as a sufficient application for a research registration; and]
(m)(1)(B)(iii)(iii) [inserted: ]
[inserted: within 45 days after receiving such a notice that contains all information required by subparagraph (A), the Attorney General shall register the applicant, or serve an order to show cause upon the applicant in accordance with section 304(c).]
(m)(1)(C)(C) [inserted: Verification of information.—]
[inserted: On request from the Attorney General, the Secretary of Health and Human Services or the Secretary of Veterans Affairs, as appropriate, shall verify information submitted by an applicant under subparagraph (A)(iii).]
(m)(2)(2) [inserted: Research subject to expedited procedure.—]
[inserted: Research described in this paragraph is research that—]
(m)(2)(A)(A) [inserted: ]
[inserted: is the subject of an application under section 505(i) of the Federal Food, Drug, and Cosmetic Act or section 351(a)(3) of the Public Health Service Act for the investigation of a drug which is in effect in accordance with section 312.40 of title 21, Code of Federal Regulations; or]
(m)(2)(B)(B) [inserted: ]
[inserted: is conducted by the Department of Health and Human Services, the Department of Justice, or the Department of Veterans Affairs or is funded partly or entirely by a grant, contract, cooperative agreement, or other transaction from the Department of Health and Human Services, the Department of Justice, or the Department of Veterans Affairs.]
(m)(3)(3) [inserted: Electronic submissions.—]
[inserted: The Attorney General shall provide a means to allow practitioners to submit notifications under paragraph (1) electronically.]
(m)(4)(4) [inserted: Limitation on amounts.—]
[inserted: A practitioner conducting research with a controlled substance in schedule I pursuant to this subsection shall be allowed to possess only the amounts of the controlled substance in schedule I identified in—]
(m)(4)(A)(A) [inserted: ]
[inserted: the notification to the Attorney General under paragraph (1); or]
(m)(4)(B)(B) [inserted: ]
[inserted: if the practitioner needs additional amounts for the research, a supplemental notification under this subsection that includes the practitioner’s name, the additional quantity needed of the substance, and an attestation that the research to be conducted with the substance is consistent with the scope of the research that was the subject of the notification under paragraph (1).]
(m)(5)(5) [inserted: Importation and exportation requirements not affected.—]
[inserted: Nothing in this section alters the requirements of part A of title III regarding the importation and exportation of controlled substances.]
(n)(n) [inserted: Transparency regarding special procedures.—]
(n)(1)(1) [inserted: In general.—]
[inserted: If the Attorney General determines, with respect to a controlled substance, that an application by a practitioner to conduct research with such substance should be considered under a process, or subject to criteria, different from the process or criteria applicable to applications to conduct research with other controlled substances in the same schedule, the Attorney General shall make public, including by posting on the website of the Drug Enforcement Administration—]
(n)(1)(A)(A) [inserted: ]
[inserted: the identities of all substances for which such determinations have been made;]
(n)(1)(B)(B) [inserted: ]
[inserted: the process and criteria that will be applied to applications to conduct research with such substances; and]
(n)(1)(C)(C) [inserted: ]
[inserted: how such process and criteria differ from those applicable to applications to conduct research with other controlled substances in the same schedule.]
(n)(2)(2) [inserted: Timing of posting.—]
[inserted: The Attorney General shall make such information public upon making such determination, regardless of whether a practitioner has submitted such an application at that time.]

21 U.S.C. § 841 Prohibited acts A

+14 −3Shown
More for 21 U.S.C. § 841
Read § 841Only this section
4 changes the bill asks for here, 4 carried out
  1. Carried out:

    in subparagraph (A), by striking clause (vi) and inserting the following:(vi) (I) 400 grams or more of a mixture or substance containing a detectable amount of fentanyl; or (II) 100 grams or more of a mixture or substance containing a detectable amount of any analogue of fentanyl that is controlled in schedule I or II or that is treated as a schedule …

  2. Carried out:

    in subparagraph (B), by striking clause (vi) and inserting the following:(vi) (I) 40 grams or more of a mixture or substance containing a detectable amount of fentanyl; or (II) 10 grams or more of a mixture or substance containing a detectable amount of any analogue of fentanyl that is controlled in schedule I or II or that is treated as a schedule I …

  3. Carried out:

    in subparagraph (C), by inserting , including a fentanyl-related substance as defined in schedule I(e) of section 202(c), after a controlled substance in schedule I or II,.

  4. Carried out:

    Section 401(b) of the Controlled Substances Act (21 U.S.C. 841(b)) is amended by adding at the end the following:(8) Past convictions involving fentanyl-Related substance.— (A) In general.— In the case of a defendant whose offense of conviction under this title involved a fentanyl-related substance (as defined in schedule I(e) of section 202(c) as of the date the offense was committed) …

§ 841(b)(1)(A)In the case of a violation of subsection (a) of this section…(v)–(viii)

Start of § 841 to (b)(1)(A)(iv) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(v)(v) (v)
10 grams or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);10 grams or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);
(vi)(vi) (vi)
(vi)(I)(I) [inserted: ]
[inserted: 400 grams or more of a mixture or substance containing a detectable amount of fentanyl; or]
(vi)(II)(II) [inserted: ]
[inserted: 100 grams or more of a mixture or substance containing a detectable amount of any analogue of fentanyl that is controlled in schedule I or II or that is treated as a schedule I controlled substance pursuant to section 203(a), except for a fentanyl-related substance as defined in schedule I(e) of section 202(c);]
(vi)[struck: 400 grams or more of a mixture or substance containing a detectable amount of N-phenyl-N- [ 1- ( 2-phenylethyl ) -4-piperidinyl ] propanamide or 100 grams or more of a mixture or substance containing a detectable amount of any analogue of N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide or a fentanyl-related substance;]
(vii)(vii) (vii)
1000 kilograms or more of a mixture or substance containing a detectable amount of marihuana, or 1,000 or more marihuana plants regardless of weight; or1000 kilograms or more of a mixture or substance containing a detectable amount of marihuana, or 1,000 or more marihuana plants regardless of weight; or
(viii)(viii) (viii)
50 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 500 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers;50 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 500 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers;

§ 841(b)(1)(B)–(E)

(b)(1)(A)–(B) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(B)(v)(v) (v)
1 gram or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);1 gram or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);
(B)(vi)(vi) (vi)
(B)(vi)(I)(I) [inserted: ]
[inserted: 40 grams or more of a mixture or substance containing a detectable amount of fentanyl; or]
(B)(vi)(II)(II) [inserted: ]
[inserted: 10 grams or more of a mixture or substance containing a detectable amount of any analogue of fentanyl that is controlled in schedule I or II or that is treated as a schedule I controlled substance pursuant to section 203(a), except for a fentanyl-related substance as defined in schedule I(e) of section 202(c);]
(B)(vi)[struck: 40 grams or more of a mixture or substance containing a detectable amount of N-phenyl-N- [ 1- ( 2-phenylethyl ) -4-piperidinyl ] propanamide or 10 grams or more of a mixture or substance containing a detectable amount of any analogue of N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide or a fentanyl-related substance;]
(B)(vii)(vii) (vii)
100 kilograms or more of a mixture or substance containing a detectable amount of marihuana, or 100 or more marihuana plants regardless of weight; or100 kilograms or more of a mixture or substance containing a detectable amount of marihuana, or 100 or more marihuana plants regardless of weight; or
(B)(viii)(viii) (viii)
5 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 50 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers;5 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 50 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers;
(B)such person shall be sentenced to a term of imprisonment which may not be less than 5 years and not more than 40 years and if death or serious bodily injury results from the use of such substance shall be not less than 20 years or more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $5,000,000 if the defendant is an individual or $25,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a serious drug felony or serious violent felony has become final, such person shall be sentenced to a term of imprisonment which may not be less than 10 years and not more than life imprisonment and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $8,000,000 if the defendant is an individual or $50,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposed under this subparagraph shall, in the absence of such a prior conviction, include a term of supervised release of at least 4 years in addition to such term of imprisonment and shall, if there was such a prior conviction, include a term of supervised release of at least 8 years in addition to such term of imprisonment. Notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under this subparagraph. No person sentenced under this subparagraph shall be eligible for parole during the term of imprisonment imposed therein.such person shall be sentenced to a term of imprisonment which may not be less than 5 years and not more than 40 years and if death or serious bodily injury results from the use of such substance shall be not less than 20 years or more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $5,000,000 if the defendant is an individual or $25,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a serious drug felony or serious violent felony has become final, such person shall be sentenced to a term of imprisonment which may not be less than 10 years and not more than life imprisonment and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $8,000,000 if the defendant is an individual or $50,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposed under this subparagraph shall, in the absence of such a prior conviction, include a term of supervised release of at least 4 years in addition to such term of imprisonment and shall, if there was such a prior conviction, include a term of supervised release of at least 8 years in addition to such term of imprisonment. Notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under this subparagraph. No person sentenced under this subparagraph shall be eligible for parole during the term of imprisonment imposed therein.
(C)(C) (C)
In the case of a controlled substance in schedule I or II, gamma hydroxybutyric acid (including when scheduled as an approved drug product for purposes of section 3(a)(1)(B) of the Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000), or 1 gram of flunitrazepam, except as provided in subparagraphs (A), (B), and (D), such person shall be sentenced to a term of imprisonment of not more than 20 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not less than twenty years or more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $1,000,000 if the defendant is an individual or $5,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 30 years and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $2,000,000 if the defendant is an individual or $10,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 3 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 6 years in addition to such term of imprisonment. Notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under the provisions of this subparagraph which provide for a mandatory term of imprisonment if death or serious bodily injury results, nor shall a person so sentenced be eligible for parole during the term of such a sentence.In the case of a controlled substance in schedule I or II,[inserted: ,] [inserted: including a fentanyl-related substance as defined in schedule I(e) of section 202(c), ]gamma hydroxybutyric acid (including when scheduled as an approved drug product for purposes of section 3(a)(1)(B) of the Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000), or 1 gram of flunitrazepam, except as provided in subparagraphs (A), (B), and (D), such person shall be sentenced to a term of imprisonment of not more than 20 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not less than twenty years or more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $1,000,000 if the defendant is an individual or $5,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 30 years and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $2,000,000 if the defendant is an individual or $10,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 3 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 6 years in addition to such term of imprisonment. Notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under the provisions of this subparagraph which provide for a mandatory term of imprisonment if death or serious bodily injury results, nor shall a person so sentenced be eligible for parole during the term of such a sentence.
(D)(D) (D)
In the case of less than 50 kilograms of marihuana, except in the case of 50 or more marihuana plants regardless of weight, 10 kilograms of hashish, or one kilogram of hashish oil, such person shall, except as provided in paragraphs (4) and (5) of this subsection, be sentenced to a term of imprisonment of not more than 5 years, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $250,000 if the defendant is an individual or $1,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 10 years, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $500,000 if the defendant is an individual or $2,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 2 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 4 years in addition to such term of imprisonment.In the case of less than 50 kilograms of marihuana, except in the case of 50 or more marihuana plants regardless of weight, 10 kilograms of hashish, or one kilogram of hashish oil, such person shall, except as provided in paragraphs (4) and (5) of this subsection, be sentenced to a term of imprisonment of not more than 5 years, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $250,000 if the defendant is an individual or $1,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 10 years, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $500,000 if the defendant is an individual or $2,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 2 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 4 years in addition to such term of imprisonment.
(E)(E) (E)

§ 841(b)–(c)

(b)(1)(E)(i)–(7) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(b)(7)(A)(A) In general.—(A) In general.—
Whoever, with intent to commit a crime of violence, as defined in section 16 of title 18 (including rape), against an individual, violates subsection (a) by distributing a controlled substance or controlled substance analogue to that individual without that individual’s knowledge, shall be imprisoned not more than 20 years and fined in accordance with title 18.Whoever, with intent to commit a crime of violence, as defined in section 16 of title 18 (including rape), against an individual, violates subsection (a) by distributing a controlled substance or controlled substance analogue to that individual without that individual’s knowledge, shall be imprisoned not more than 20 years and fined in accordance with title 18.
(b)(7)(B)(B) Definition.—(B) Definition.—
For purposes of this paragraph, the term “without that individual’s knowledge” means that the individual is unaware that a substance with the ability to alter that individual’s ability to appraise conduct or to decline participation in or communicate unwillingness to participate in conduct is administered to the individual.For purposes of this paragraph, the term “without that individual’s knowledge” means that the individual is unaware that a substance with the ability to alter that individual’s ability to appraise conduct or to decline participation in or communicate unwillingness to participate in conduct is administered to the individual.
(b)(8)(8) [inserted: Past convictions involving fentanyl-Related substance.—]
(b)(8)(A)(A) [inserted: In general.—]
[inserted: In the case of a defendant whose offense of conviction under this title involved a fentanyl-related substance (as defined in schedule I(e) of section 202(c) as of the date the offense was committed) that has since been removed from designation as a fentanyl-related substance for purposes of this title and has been placed on any schedule other than schedule I or II or has been removed from the controlled substance schedules, the sentencing court may, on motion of the defendant, the Bureau of Prisons, the attorney for the Government, or on its own motion, after considering the factors set forth in section 3553(a) of title 18, United States Code, vacate the previously imposed sentence, or impose a reduced sentence on any count of conviction as if the removal or placement was in effect at the time that the offense was committed. Nothing in this section may be construed to require a court to vacate or reduce any sentence.]
(b)(8)(B)(B) [inserted: Defendant not required to be present.—]
[inserted: Notwithstanding rule 43 of the Federal Rules of Criminal Procedure, the defendant is not required to be present at any hearing on whether to vacate or reduce a sentence pursuant to this section.]
(c)(c) Offenses involving listed chemicals(c) Offenses involving listed chemicals
Any person who knowingly or intentionally—Any person who knowingly or intentionally—
(c)(1)(1) (1)
possesses a listed chemical with intent to manufacture a controlled substance except as authorized by this subchapter;possesses a listed chemical with intent to manufacture a controlled substance except as authorized by this subchapter;

Rest of § 841 unchanged

21 U.S.C. § 960 Prohibited acts A

+11 −3Shown
More for 21 U.S.C. § 960
Read § 960Only this section
4 changes the bill asks for here, 4 carried out
  1. Carried out:

    in paragraph (1), by striking subparagraph (F) and inserting the following:(F) (i) 400 grams or more of a mixture or substance containing a detectable amount of fentanyl; or (ii) 100 grams or more of a mixture or substance containing a detectable amount of any analogue of fentanyl that is controlled in schedule I or II or that is treated as a schedule …

  2. Carried out:

    in paragraph (2), by striking subparagraph (F) and inserting the following:(F) (i) 40 grams or more of a mixture or substance containing a detectable amount of fentanyl; or (ii) 10 grams or more of a mixture or substance containing a detectable amount of any analogue of fentanyl that is controlled in schedule I or II or that is treated as a schedule I …

  3. Carried out:

    in paragraph (3), by inserting including a fentanyl-related substance as defined in schedule I(e) of section 202(c) of the Controlled Substances Act, after a controlled substance in schedule I or II,.

  4. Carried out:

    Section 1010(b) of the Controlled Substances Import and Export Act (21 U.S.C. 960(b)) is amended by adding at the end the following:(8) In the case of a defendant whose offense of conviction under this title involved a fentanyl-related substance (as defined in schedule I(e) of section 202(c) of the Controlled Substances Act as of the date the offense was committed) that has since been removed from …

§ 960(b)(1)In the case of a violation of subsection (a) of this section…(E)–(H)

Start of § 960 to (b)(1)(D) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(E)(E) (E)
10 grams or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);10 grams or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);
(F)(F) (F)
(F)(i)(i) [inserted: ]
[inserted: 400 grams or more of a mixture or substance containing a detectable amount of fentanyl; or]
(F)(ii)(ii) [inserted: ]
[inserted: 100 grams or more of a mixture or substance containing a detectable amount of any analogue of fentanyl that is controlled in schedule I or II or that is treated as a schedule I controlled substance pursuant to section 203(a) of the Controlled Substances Act, except for a fentanyl-related substance as defined in schedule I(e) of section 202(c) of the Controlled Substances Act;]
(F)[struck: 400 grams or more of a mixture or substance containing a detectable amount of N-phenyl-N- [1- ( 2-phenylethyl ) -4-piperidinyl] propanamide or 100 grams or more of a mixture or substance containing a detectable amount of any analogue of N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide or a fentanyl-related substance;]
(G)(G) (G)
1000 kilograms or more of a mixture or substance containing a detectable amount of marihuana; or1000 kilograms or more of a mixture or substance containing a detectable amount of marihuana; or
(H)(H) (H)
50 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 500 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers.150 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 500 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers.1

§ 960(b)–(d)

(b)(1)–(2) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(b)(2)(E)(E) (E)
1 gram or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);1 gram or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);
(b)(2)(F)(F) (F)
(b)(2)(F)(i)(i) [inserted: ]
[inserted: 40 grams or more of a mixture or substance containing a detectable amount of fentanyl; or]
(b)(2)(F)(ii)(ii) [inserted: ]
[inserted: 10 grams or more of a mixture or substance containing a detectable amount of any analogue of fentanyl that is controlled in schedule I or II or that is treated as a schedule I controlled substance pursuant to section 203(a) of the Controlled Substances Act, except for a fentanyl-related substance as defined in schedule I(e) of section 202(c) of the Controlled Substances Act;]
(b)(2)(F)[struck: 40 grams or more of a mixture or substance containing a detectable amount of N-phenyl-N- [1- ( 2-phenylethyl ) -4-piperidinyl] propanamide or 10 grams or more of a mixture or substance containing a detectable amount of any analogue of N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide or a fentanyl-related substance;]
(b)(2)(G)(G) (G)
100 kilograms or more of a mixture or substance containing a detectable amount of marihuana; or100 kilograms or more of a mixture or substance containing a detectable amount of marihuana; or
(b)(2)(H)(H) (H)
5 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 50 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers.15 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 50 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers.1
(b)(2)the person committing such violation shall be sentenced to a term of imprisonment of not less than 5 years and not more than 40 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not less than twenty years and not more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $5,000,000 if the defendant is an individual or $25,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a serious drug felony or serious violent felony has become final, such person shall be sentenced to a term of imprisonment of not less than 10 years and not more than life imprisonment and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $8,000,000 if the defendant is an individual or $50,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposed under this paragraph shall, in the absence of such a prior conviction, include a term of supervised release of at least 4 years in addition to such term of imprisonment and shall, if there was such a prior conviction, include a term of supervised release of at least 8 years in addition to such term of imprisonment. Notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under this paragraph. No person sentenced under this paragraph shall be eligible for parole during the term of imprisonment imposed therein.the person committing such violation shall be sentenced to a term of imprisonment of not less than 5 years and not more than 40 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not less than twenty years and not more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $5,000,000 if the defendant is an individual or $25,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a serious drug felony or serious violent felony has become final, such person shall be sentenced to a term of imprisonment of not less than 10 years and not more than life imprisonment and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $8,000,000 if the defendant is an individual or $50,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposed under this paragraph shall, in the absence of such a prior conviction, include a term of supervised release of at least 4 years in addition to such term of imprisonment and shall, if there was such a prior conviction, include a term of supervised release of at least 8 years in addition to such term of imprisonment. Notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under this paragraph. No person sentenced under this paragraph shall be eligible for parole during the term of imprisonment imposed therein.
(b)(3)(3) (3)
In the case of a violation under subsection (a) of this section involving a controlled substance in schedule I or II, gamma hydroxybutyric acid (including when scheduled as an approved drug product for purposes of section 3(a)(1)(B) of the Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000), or flunitrazepam, the person committing such violation shall, except as provided in paragraphs (1), (2), and (4), be sentenced to a term of imprisonment of not more than 20 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not less than twenty years and not more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $1,000,000 if the defendant is an individual or $5,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 30 years and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $2,000,000 if the defendant is an individual or $10,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 3 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 6 years in addition to such term of imprisonment. Notwithstanding the prior sentence, and notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under the provisions of this paragraph which provide for a mandatory term of imprisonment if death or serious bodily injury results.In the case of a violation under subsection (a) of this section involving a controlled substance in schedule I or II, [inserted: including a fentanyl-related substance as defined in schedule I(e) of section 202(c) of the Controlled Substances Act, ]gamma hydroxybutyric acid (including when scheduled as an approved drug product for purposes of section 3(a)(1)(B) of the Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000), or flunitrazepam, the person committing such violation shall, except as provided in paragraphs (1), (2), and (4), be sentenced to a term of imprisonment of not more than 20 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not less than twenty years and not more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $1,000,000 if the defendant is an individual or $5,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 30 years and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $2,000,000 if the defendant is an individual or $10,000,000 if the defendant is other than an individual, or both. Notwithstanding section 3583 of title 18, any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 3 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 6 years in addition to such term of imprisonment. Notwithstanding the prior sentence, and notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under the provisions of this paragraph which provide for a mandatory term of imprisonment if death or serious bodily injury results.
(b)(4)(4) (4)
In the case of a violation under subsection (a) with respect to less than 50 kilograms of marihuana, except in the case of 100 or more marihuana plants regardless of weight, less than 10 kilograms of hashish, or less than one kilogram of hashish oil, the person committing such violation shall be sentenced in accordance with section 841(b)(1)(D) of this title.In the case of a violation under subsection (a) with respect to less than 50 kilograms of marihuana, except in the case of 100 or more marihuana plants regardless of weight, less than 10 kilograms of hashish, or less than one kilogram of hashish oil, the person committing such violation shall be sentenced in accordance with section 841(b)(1)(D) of this title.
(b)(5)(5) (5)
In the case of a violation of subsection (a) involving a controlled substance in schedule III, such person shall be sentenced in accordance with section 841(b)(1) of this title.In the case of a violation of subsection (a) involving a controlled substance in schedule III, such person shall be sentenced in accordance with section 841(b)(1) of this title.
(b)(6)(6) (6)
In the case of a violation of subsection (a) involving a controlled substance in schedule IV, such person shall be sentenced in accordance with section 841(b)(2) of this title.In the case of a violation of subsection (a) involving a controlled substance in schedule IV, such person shall be sentenced in accordance with section 841(b)(2) of this title.
(b)(7)(7) (7)
In the case of a violation of subsection (a) involving a controlled substance in schedule V, such person shall be sentenced in accordance with section 841(b)(3) of this title.In the case of a violation of subsection (a) involving a controlled substance in schedule V, such person shall be sentenced in accordance with section 841(b)(3) of this title.
(b)(8)(8) [inserted: ]
[inserted: In the case of a defendant whose offense of conviction under this title involved a fentanyl-related substance (as defined in schedule I(e) of section 202(c) of the Controlled Substances Act as of the date the offense was committed) that has since been removed from designation as a fentanyl-related substance for purposes of this title and has been placed on any schedule other than schedule I or II or has been removed from the controlled substance schedules, the sentencing court may, on motion of the defendant, the Bureau of Prisons, the attorney for the Government, or on its own motion, after considering the factors set forth in section 3553(a) of title 18, United States Code, vacate the previously imposed sentence, or impose a reduced sentence on any count of conviction as if the removal or placement was in effect at the time that the offense was committed. Nothing in this section may be construed to require a court to vacate or reduce any sentence.]
(c)(c) Repealed. Pub. L. 98–473, title II, § 225, formerly § 225(a), Oct. 12, 1984, 98 Stat. 2030, as amended by Pub. L. 99–570, title I, § 1005(c), Oct. 27, 1986, 100 Stat. 3207–6(c) Repealed. Pub. L. 98–473, title II, § 225, formerly § 225(a), Oct. 12, 1984, 98 Stat. 2030, as amended by Pub. L. 99–570, title I, § 1005(c), Oct. 27, 1986, 100 Stat. 3207–6
(d)(d) Penalty for importation or exportation(d) Penalty for importation or exportation
A person who knowingly or intentionally—A person who knowingly or intentionally—

Rest of § 960 unchanged

21 U.S.C. § 812 Schedules of controlled substances

Couldn't place the change
More for 21 U.S.C. § 812
Read § 812Only this section

The bill's words for this section

  1. Not carried out:

    Section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end of schedule I the following:(e) (1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of fentanyl-related substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such …

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: adding at the end of schedule i the following: QCONTENT.

Step through the changes